EGCG downregulated molecular signaling factors such as epidermal growth factor receptor (EGFR), extracellular signal-regulated kinase 1/2 (ERK1/2), and mitogen-activated protein kinase (MAPK) and inhibited tumor microvessel density dose-dependently in xenografts of these cells (Figure 2). This evidence concerns the gene EGFR and neoplasm.